Unknown

Dataset Information

0

Salvage second transplantation in relapsed multiple myeloma.

ABSTRACT:

SUBMITTER: Dhakal B 

PROVIDER: S-EPMC8020391 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Salvage second hematopoietic cell transplantation in myeloma.
| S-EPMC3816739 | biostudies-literature
Unknown Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
| S-EPMC8392190 | biostudies-literature
Unknown American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.
| S-EPMC4757494 | biostudies-literature
Unknown The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myeloma.
| S-EPMC6893102 | biostudies-literature
Unknown Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report.
| S-EPMC6339830 | biostudies-literature
Unknown Selinexor in relapsed/refractory multiple myeloma.
| S-EPMC7285937 | biostudies-literature
Unknown CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.
| S-EPMC4975432 | biostudies-literature
Unknown Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.
| S-EPMC8764606 | biostudies-literature
Unknown Phase 1/2 Trial of Carfilzomib Plus High-Dose Melphalan Preparative Regimen for Salvage Autologous Hematopoietic Cell Transplantation Followed by Maintenance Carfilzomib in Patients with Relapsed/Refractory Multiple Myeloma.
| S-EPMC7590532 | biostudies-literature
Unknown Treatment of relapsed and refractory multiple myeloma.
| S-EPMC7386890 | biostudies-literature